DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 160 filers reported holding DIPLOMAT PHARMACY INC in Q4 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,053,000 | -19.5% | 214,845 | 0.0% | 0.05% | -13.2% |
| Q2 2019 | $1,308,000 | +4.8% | 214,845 | 0.0% | 0.05% | +3.9% |
| Q1 2019 | $1,248,000 | -81.7% | 214,845 | -57.5% | 0.05% | -82.5% |
| Q4 2018 | $6,807,000 | -20.1% | 505,701 | +15.2% | 0.29% | -5.8% |
| Q3 2018 | $8,521,000 | -24.1% | 439,001 | 0.0% | 0.31% | -27.5% |
| Q2 2018 | $11,221,000 | +26.8% | 439,001 | 0.0% | 0.43% | +23.8% |
| Q1 2018 | $8,846,000 | -31.2% | 439,001 | -31.5% | 0.34% | -30.6% |
| Q4 2017 | $12,855,000 | +34.4% | 640,492 | +38.7% | 0.50% | +45.0% |
| Q3 2017 | $9,562,000 | +39.9% | 461,712 | 0.0% | 0.34% | +35.2% |
| Q2 2017 | $6,833,000 | +229.0% | 461,712 | +254.6% | 0.25% | +212.3% |
| Q1 2017 | $2,077,000 | +26.6% | 130,223 | 0.0% | 0.08% | +15.7% |
| Q4 2016 | $1,641,000 | -32.8% | 130,223 | +49.4% | 0.07% | -25.5% |
| Q3 2016 | $2,441,000 | – | 87,163 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |